25 XP   0   0   10

Zhejiang Hisun Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Zhejiang Hisun Pharmaceutical Co Ltd together

PenkeI guess you are interested in Zhejiang Hisun Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhejiang Hisun Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zhejiang Hisun Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Hisun Pharmaceutical Co Ltd.

Quick analysis of Zhejiang Hisun Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Zhejiang Hisun Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.17
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥6.90
Expected worth in 1 year
¥10.16
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
¥4.52
Return On Investment
60.0%

For what price can you sell your share?

Current Price per Share
¥7.54
Expected price per share
¥6.43 - ¥8.22
How sure are you?
50%

1. Valuation of Zhejiang Hisun Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥7.54

Intrinsic Value Per Share

¥6.98 - ¥32.03

Total Value Per Share

¥13.87 - ¥38.92

2. Growth of Zhejiang Hisun Pharmaceutical Co Ltd (5 min.)




Is Zhejiang Hisun Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1.1b$1b$135.8m11.8%

How much money is Zhejiang Hisun Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$67.4m$67.1m$297.6k0.4%
Net Profit Margin4.1%4.0%--

How much money comes from the company's main activities?

3. Financial Health of Zhejiang Hisun Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Zhejiang Hisun Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Zhejiang Hisun Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Zhejiang Hisun Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Zhejiang Hisun Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Zhejiang Hisun Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Zhejiang Hisun Pharmaceutical Co Ltd is ¥7.54. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zhejiang Hisun Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zhejiang Hisun Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥6.90. Based on the TTM, the Book Value Change Per Share is ¥0.82 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.75 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.32 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zhejiang Hisun Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.060.7%0.060.7%0.060.7%0.020.3%0.020.2%
Usd Book Value Change Per Share0.111.5%0.111.5%-0.10-1.4%0.010.1%0.040.5%
Usd Dividend Per Share0.040.6%0.040.6%0.050.6%0.050.7%0.050.7%
Usd Total Gains Per Share0.162.1%0.162.1%-0.06-0.7%0.060.8%0.091.2%
Usd Price Per Share1.52-1.52-1.93-1.65-1.87-
Price to Earnings Ratio27.22-27.22-34.71-43.56-293.43-
Price-to-Total Gains Ratio9.74-9.74--34.22-50.40-45.97-
Price to Book Ratio1.60-1.60-2.30-1.85-2.14-
Price-to-Total Gains Ratio9.74-9.74--34.22-50.40-45.97-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.04052
Number of shares961
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.05
Usd Book Value Change Per Share0.110.01
Usd Total Gains Per Share0.160.06
Gains per Quarter (961 shares)149.9760.44
Gains per Year (961 shares)599.89241.77
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
116743259020240232
2335865119040480474
350212971790605120716
467017302390807160958
58372162299010092001200
610052595359012112401442
711723027419014132801684
813393460479016153201926
915073892539018163602168
1016744325599020184002410

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%8.02.00.080.0%21.02.00.091.3%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%5.05.00.050.0%18.05.00.078.3%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%23.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%22.01.00.095.7%

Fundamentals of Zhejiang Hisun Pharmaceutical Co Ltd

About Zhejiang Hisun Pharmaceutical Co Ltd

Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients and finished dosage form products. It offers products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, liver care, and orthopaedics treatment; and weight loss, anti-viral, anti-TB, animal healthcare, and others. The company also exports its products to approximately 70 countries worldwide. The company was founded in 1956 and is headquartered in Taizhou, China.

Fundamental data was last updated by Penke on 2024-04-17 06:26:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Zhejiang Hisun Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Zhejiang Hisun Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Zhejiang Hisun Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 4.1% means that ¥0.04 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The MRQ is 4.1%. The company is making a profit. +1
  • The TTM is 4.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.1%TTM4.1%0.0%
TTM4.1%YOY4.0%+0.1%
TTM4.1%5Y1.6%+2.5%
5Y1.6%10Y1.4%+0.2%
1.1.2. Return on Assets

Shows how efficient Zhejiang Hisun Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zhejiang Hisun Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.6% Return on Assets means that Zhejiang Hisun Pharmaceutical Co Ltd generated ¥0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The MRQ is 2.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.6%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.6%TTM2.6%0.0%
TTM2.6%YOY2.5%+0.1%
TTM2.6%5Y1.1%+1.5%
5Y1.1%10Y0.9%+0.2%
1.1.3. Return on Equity

Shows how efficient Zhejiang Hisun Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zhejiang Hisun Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 6.1% Return on Equity means Zhejiang Hisun Pharmaceutical Co Ltd generated ¥0.06 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The MRQ is 6.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 6.1%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ6.1%TTM6.1%0.0%
TTM6.1%YOY6.7%-0.6%
TTM6.1%5Y2.5%+3.6%
5Y2.5%10Y2.2%+0.3%

1.2. Operating Efficiency of Zhejiang Hisun Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Zhejiang Hisun Pharmaceutical Co Ltd is operating .

  • Measures how much profit Zhejiang Hisun Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zhejiang Hisun Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 7.9% means the company generated ¥0.08  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The MRQ is 7.9%. The company is operating less efficient.
  • The TTM is 7.9%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ7.9%TTM7.9%0.0%
TTM7.9%YOY7.0%+0.9%
TTM7.9%5Y4.2%+3.8%
5Y4.2%10Y3.9%+0.3%
1.2.2. Operating Ratio

Measures how efficient Zhejiang Hisun Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.48 means that the operating costs are ¥1.48 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The MRQ is 1.485. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.485. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.485TTM1.4850.000
TTM1.485YOY1.502-0.017
TTM1.4855Y1.510-0.025
5Y1.51010Y1.382+0.128

1.3. Liquidity of Zhejiang Hisun Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Zhejiang Hisun Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.90 means the company has ¥0.90 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The MRQ is 0.899. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.899. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.899TTM0.8990.000
TTM0.899YOY0.724+0.174
TTM0.8995Y0.746+0.152
5Y0.74610Y0.663+0.084
1.3.2. Quick Ratio

Measures if Zhejiang Hisun Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zhejiang Hisun Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.34 means the company can pay off ¥0.34 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The MRQ is 0.344. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.344. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.344TTM0.3440.000
TTM0.344YOY0.239+0.106
TTM0.3445Y0.253+0.092
5Y0.25310Y0.272-0.019

1.4. Solvency of Zhejiang Hisun Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Zhejiang Hisun Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zhejiang Hisun Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.56 means that Zhejiang Hisun Pharmaceutical Co Ltd assets are financed with 55.6% credit (debt) and the remaining percentage (100% - 55.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The MRQ is 0.556. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.556. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.556TTM0.5560.000
TTM0.556YOY0.621-0.064
TTM0.5565Y0.617-0.061
5Y0.61710Y0.600+0.017
1.4.2. Debt to Equity Ratio

Measures if Zhejiang Hisun Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zhejiang Hisun Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 129.3% means that company has ¥1.29 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The MRQ is 1.293. The company is able to pay all its debts with equity. +1
  • The TTM is 1.293. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.293TTM1.2930.000
TTM1.293YOY1.647-0.354
TTM1.2935Y1.873-0.580
5Y1.87310Y1.781+0.092

2. Market Valuation of Zhejiang Hisun Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Zhejiang Hisun Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Zhejiang Hisun Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 27.22 means the investor is paying ¥27.22 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The EOD is 18.623. Based on the earnings, the company is fair priced.
  • The MRQ is 27.218. Based on the earnings, the company is overpriced. -1
  • The TTM is 27.218. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD18.623MRQ27.218-8.595
MRQ27.218TTM27.2180.000
TTM27.218YOY34.706-7.489
TTM27.2185Y43.563-16.345
5Y43.56310Y293.427-249.865
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The EOD is 5.933. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 8.671. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 8.671. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD5.933MRQ8.671-2.738
MRQ8.671TTM8.6710.000
TTM8.671YOY15.167-6.496
TTM8.6715Y-10.213+18.884
5Y-10.21310Y-18.980+8.768
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Zhejiang Hisun Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Zhejiang Hisun Pharmaceutical Co Ltd:

  • The EOD is 1.093. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.598. Based on the equity, the company is underpriced. +1
  • The TTM is 1.598. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.093MRQ1.598-0.505
MRQ1.598TTM1.5980.000
TTM1.598YOY2.300-0.703
TTM1.5985Y1.850-0.252
5Y1.85010Y2.136-0.287
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Zhejiang Hisun Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.8150.8150%-0.754+193%0.075+982%0.259+214%
Book Value Per Share--6.8976.8970%6.081+13%6.457+7%6.399+8%
Current Ratio--0.8990.8990%0.724+24%0.746+20%0.663+36%
Debt To Asset Ratio--0.5560.5560%0.621-10%0.617-10%0.600-7%
Debt To Equity Ratio--1.2931.2930%1.647-21%1.873-31%1.781-27%
Dividend Per Share--0.3160.3160%0.345-9%0.380-17%0.374-16%
Eps--0.4050.4050%0.403+0%0.165+146%0.127+218%
Free Cash Flow Per Share--1.2711.2710%0.922+38%0.499+155%-0.213+117%
Free Cash Flow To Equity Per Share--0.0250.0250%-0.795+3330%-0.726+3049%-0.284+1253%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--32.025--------
Intrinsic Value_10Y_min--6.975--------
Intrinsic Value_1Y_max--1.463--------
Intrinsic Value_1Y_min--0.017--------
Intrinsic Value_3Y_max--5.726--------
Intrinsic Value_3Y_min--0.642--------
Intrinsic Value_5Y_max--11.594--------
Intrinsic Value_5Y_min--1.910--------
Market Cap9107339438.080-46%13310726871.04013310726871.0400%16898100628.480-21%14455787585.536-8%16388379508.736-19%
Net Profit Margin--0.0410.0410%0.040+1%0.016+162%0.014+197%
Operating Margin--0.0790.0790%0.070+13%0.042+90%0.039+105%
Operating Ratio--1.4851.4850%1.502-1%1.510-2%1.382+7%
Pb Ratio1.093-46%1.5981.5980%2.300-31%1.850-14%2.136-25%
Pe Ratio18.623-46%27.21827.2180%34.706-22%43.563-38%293.427-91%
Price Per Share7.540-46%11.02011.0200%13.990-21%11.968-8%13.568-19%
Price To Free Cash Flow Ratio5.933-46%8.6718.6710%15.167-43%-10.213+218%-18.980+319%
Price To Total Gains Ratio6.668-46%9.7459.7450%-34.222+451%50.398-81%45.968-79%
Quick Ratio--0.3440.3440%0.239+44%0.253+36%0.272+27%
Return On Assets--0.0260.0260%0.025+4%0.011+146%0.009+192%
Return On Equity--0.0610.0610%0.067-9%0.025+142%0.022+175%
Total Gains Per Share--1.1311.1310%-0.409+136%0.456+148%0.633+79%
Usd Book Value--1149566466.0281149566466.0280%1013680817.377+13%1076219443.807+7%1066685966.412+8%
Usd Book Value Change Per Share--0.1130.1130%-0.104+193%0.010+982%0.036+214%
Usd Book Value Per Share--0.9520.9520%0.839+13%0.891+7%0.883+8%
Usd Dividend Per Share--0.0440.0440%0.048-9%0.053-17%0.052-16%
Usd Eps--0.0560.0560%0.056+0%0.023+146%0.018+218%
Usd Free Cash Flow--211846714.916211846714.9160%153752316.156+38%83184016.066+155%-35483997.233+117%
Usd Free Cash Flow Per Share--0.1750.1750%0.127+38%0.069+155%-0.029+117%
Usd Free Cash Flow To Equity Per Share--0.0030.0030%-0.110+3330%-0.100+3049%-0.039+1253%
Usd Market Cap1256812842.455-46%1836880308.2041836880308.2040%2331937886.730-21%1994898686.804-8%2261596372.206-19%
Usd Price Per Share1.041-46%1.5211.5210%1.931-21%1.652-8%1.872-19%
Usd Profit--67488221.63167488221.6310%67190593.447+0%27426845.356+146%21199355.229+218%
Usd Revenue--1661063231.2691661063231.2690%1674832275.580-1%1567315039.623+6%1441171399.658+15%
Usd Total Gains Per Share--0.1560.1560%-0.056+136%0.063+148%0.087+79%
 EOD+4 -4MRQTTM+0 -0YOY+28 -75Y+28 -710Y+27 -8

3.2. Fundamental Score

Let's check the fundamental score of Zhejiang Hisun Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1518.623
Price to Book Ratio (EOD)Between0-11.093
Net Profit Margin (MRQ)Greater than00.041
Operating Margin (MRQ)Greater than00.079
Quick Ratio (MRQ)Greater than10.344
Current Ratio (MRQ)Greater than10.899
Debt to Asset Ratio (MRQ)Less than10.556
Debt to Equity Ratio (MRQ)Less than11.293
Return on Equity (MRQ)Greater than0.150.061
Return on Assets (MRQ)Greater than0.050.026
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Zhejiang Hisun Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.224
Ma 20Greater thanMa 507.603
Ma 50Greater thanMa 1007.764
Ma 100Greater thanMa 2008.501
OpenGreater thanClose7.360
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets18,777,887
Total Liabilities10,447,695
Total Stockholder Equity8,079,089
 As reported
Total Liabilities 10,447,695
Total Stockholder Equity+ 8,079,089
Total Assets = 18,777,887

Assets

Total Assets18,777,887
Total Current Assets6,409,130
Long-term Assets12,368,757
Total Current Assets
Cash And Cash Equivalents 1,398,783
Net Receivables 2,455,209
Inventory 1,914,136
Other Current Assets 39,213
Total Current Assets  (as reported)6,409,130
Total Current Assets  (calculated)5,807,342
+/- 601,789
Long-term Assets
Property Plant Equipment 9,100,515
Intangible Assets 1,520,647
Other Assets 449,272
Long-term Assets  (as reported)12,368,757
Long-term Assets  (calculated)11,070,433
+/- 1,298,324

Liabilities & Shareholders' Equity

Total Current Liabilities7,133,080
Long-term Liabilities3,314,615
Total Stockholder Equity8,079,089
Total Current Liabilities
Short Long Term Debt 2,399,408
Accounts payable 1,302,666
Other Current Liabilities 915,696
Total Current Liabilities  (as reported)7,133,080
Total Current Liabilities  (calculated)4,617,770
+/- 2,515,310
Long-term Liabilities
Long term Debt 3,057,117
Capital Lease Obligations Min Short Term Debt32,380
Deferred Long Term Liability 194,454
Long-term Liabilities  (as reported)3,314,615
Long-term Liabilities  (calculated)3,283,951
+/- 30,665
Total Stockholder Equity
Retained Earnings 2,312,398
Other Stockholders Equity 439,188
Total Stockholder Equity (as reported)8,079,089
Total Stockholder Equity (calculated)2,751,586
+/- 5,327,503
Other
Capital Stock1,198,182
Common Stock Shares Outstanding 1,198,182
Net Debt 4,057,742
Net Invested Capital 13,535,614
Net Working Capital -723,950
Property Plant and Equipment Gross 9,100,515



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
1,206,908
1,298,922
1,575,522
1,873,739
2,179,803
2,605,873
2,812,740
2,985,559
4,121,317
5,198,691
5,921,673
8,230,982
10,569,092
13,972,087
17,298,304
19,174,426
20,758,272
21,636,419
21,853,646
21,465,563
20,859,772
19,374,263
18,777,887
18,777,88719,374,26320,859,77221,465,56321,853,64621,636,41920,758,27219,174,42617,298,30413,972,08710,569,0928,230,9825,921,6735,198,6914,121,3172,985,5592,812,7402,605,8732,179,8031,873,7391,575,5221,298,9221,206,908
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,924,038
7,221,143
6,944,132
6,087,791
7,684,307
7,347,865
6,363,985
6,409,130
6,409,1306,363,9857,347,8657,684,3076,087,7916,944,1327,221,1436,924,038000000000000000
       Cash And Cash Equivalents 
205,649
105,259
158,688
113,441
222,530
274,197
190,357
200,010
404,494
640,536
494,193
1,350,076
1,633,506
2,215,193
2,550,506
2,263,812
2,690,895
2,314,372
1,894,516
1,764,160
2,059,091
1,295,750
1,398,783
1,398,7831,295,7502,059,0911,764,1601,894,5162,314,3722,690,8952,263,8122,550,5062,215,1931,633,5061,350,076494,193640,536404,494200,010190,357274,197222,530113,441158,688105,259205,649
       Short-term Investments 
94,895
64,123
0
0
0
0
0
0
0
71
0
0
0
0
400,226
695,000
300,000
246,000
0
0
358
3,053
0
03,05335800246,000300,000695,000400,226000071000000064,12394,895
       Net Receivables 
126,558
111,633
139,141
229,639
221,398
262,588
389,529
404,983
532,966
723,105
755,259
882,810
998,095
1,439,296
1,732,117
1,358,075
1,482,639
1,578,188
1,685,906
3,460,155
1,632,183
2,092,921
2,455,209
2,455,2092,092,9211,632,1833,460,1551,685,9061,578,1881,482,6391,358,0751,732,1171,439,296998,095882,810755,259723,105532,966404,983389,529262,588221,398229,639139,141111,633126,558
       Other Current Assets 
40,542
5,207
9,548
25,845
21,309
23,422
41,258
68,245
128,008
107,044
94,625
93,028
548,466
452,582
557,052
589,695
684,423
756,373
492,366
477,197
470,344
389,286
39,213
39,213389,286470,344477,197492,366756,373684,423589,695557,052452,582548,46693,02894,625107,044128,00868,24541,25823,42221,30925,8459,5485,20740,542
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,537,129
14,692,287
15,765,855
13,781,257
13,511,907
13,010,278
12,368,757
12,368,75713,010,27813,511,90713,781,25715,765,85514,692,28713,537,1290000000000000000
       Property Plant Equipment 
557,992
784,729
996,156
1,192,493
1,394,993
1,583,511
1,726,786
1,887,526
2,434,697
3,048,819
3,667,156
4,652,047
5,929,638
7,579,113
9,150,311
10,525,460
11,515,477
12,125,578
12,636,854
10,781,078
10,369,413
9,753,838
9,100,515
9,100,5159,753,83810,369,41310,781,07812,636,85412,125,57811,515,47710,525,4609,150,3117,579,1135,929,6384,652,0473,667,1563,048,8192,434,6971,887,5261,726,7861,583,5111,394,9931,192,493996,156784,729557,992
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,790
92,603
68,123
40,895
26,471
1,421
1,421
1,421
0
01,4211,4211,42126,47140,89568,12392,60311,79000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
227,218
207,741
347,380
352,113
0
0
0
0
0000352,113347,380207,741227,218000000000000000
       Intangible Assets 
48,971
57,313
73,051
62,545
55,302
9,222
4,821
1,846
19,293
51,666
59,794
149,880
205,357
250,796
738,851
814,169
1,496,109
1,826,442
2,395,615
1,351,760
1,341,658
1,593,238
1,520,647
1,520,6471,593,2381,341,6581,351,7602,395,6151,826,4421,496,109814,169738,851250,796205,357149,88059,79451,66619,2931,8464,8219,22255,30262,54573,05157,31348,971
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
154,369
233,790
178,128
50,156
10,553,668
61,830
52,006
52,00661,83010,553,66850,156178,128233,790154,3690000000000000000
> Total Liabilities 
449,008
514,745
750,693
871,955
977,761
1,377,880
1,542,184
1,608,539
2,572,096
2,768,078
3,177,438
3,637,421
5,371,378
8,013,892
9,033,647
11,009,168
12,719,040
13,761,135
14,475,028
13,783,024
12,603,176
12,028,750
10,447,695
10,447,69512,028,75012,603,17613,783,02414,475,02813,761,13512,719,04011,009,1689,033,6478,013,8925,371,3783,637,4213,177,4382,768,0782,572,0961,608,5391,542,1841,377,880977,761871,955750,693514,745449,008
   > Total Current Liabilities 
231,775
311,745
655,273
709,748
810,350
1,262,056
1,367,534
1,324,539
1,975,522
1,485,094
1,579,277
1,580,466
2,930,404
5,085,912
5,439,994
6,582,700
7,346,169
8,080,989
9,556,936
9,929,312
10,530,286
8,784,874
7,133,080
7,133,0808,784,87410,530,2869,929,3129,556,9368,080,9897,346,1696,582,7005,439,9945,085,9122,930,4041,580,4661,579,2771,485,0941,975,5221,324,5391,367,5341,262,056810,350709,748655,273311,745231,775
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
986,051
4,376,900
5,276,522
5,683,494
0
0
0
0
00005,683,4945,276,5224,376,900986,051000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
986,051
4,376,900
5,276,522
5,683,494
4,456,149
5,111,621
3,988,481
2,399,408
2,399,4083,988,4815,111,6214,456,1495,683,4945,276,5224,376,900986,051000000000000000
       Accounts payable 
69,235
82,931
149,462
200,602
235,968
318,892
288,319
293,643
387,867
481,219
529,641
557,167
773,240
1,072,369
890,440
1,028,252
842,294
793,246
1,008,130
1,123,845
1,355,172
1,037,340
1,302,666
1,302,6661,037,3401,355,1721,123,8451,008,130793,246842,2941,028,252890,4401,072,369773,240557,167529,641481,219387,867293,643288,319318,892235,968200,602149,46282,93169,235
       Other Current Liabilities 
113,540
119,614
136,811
255,070
184,313
203,012
169,681
255,896
345,155
299,875
323,977
292,943
483,041
736,682
1,104,824
556,927
790,156
808,751
985,325
911,455
833,160
1,071,185
915,696
915,6961,071,185833,160911,455985,325808,751790,156556,9271,104,824736,682483,041292,943323,977299,875345,155255,896169,681203,012184,313255,070136,811119,614113,540
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,372,871
5,680,146
4,918,092
3,853,713
2,072,890
3,243,876
3,314,615
3,314,6153,243,8762,072,8903,853,7134,918,0925,680,1465,372,8710000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-986,051
-4,376,900
-5,276,522
-5,683,494
0
47,114
37,557
32,380
32,38037,55747,1140-5,683,494-5,276,522-4,376,900-986,051000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,134
152,774
152,200
602,200
661,118
211,118
0
0211,118661,118602,200152,200152,7744,1340000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
341,438
654,311
1,036,035
1,353,467
606,198
621,841
187,170
194,454
194,454187,170621,841606,1981,353,4671,036,035654,311341,438000000000000000
> Total Stockholder Equity
743,927
764,801
802,531
975,686
1,174,318
1,209,877
1,248,918
1,363,002
1,513,395
2,390,717
2,698,132
4,500,434
4,685,961
4,886,816
7,023,938
6,919,578
6,755,160
6,722,515
6,183,497
6,274,220
6,678,665
7,303,285
8,079,089
8,079,0897,303,2856,678,6656,274,2206,183,4976,722,5156,755,1606,919,5787,023,9384,886,8164,685,9614,500,4342,698,1322,390,7171,513,3951,363,0021,248,9181,209,8771,174,318975,686802,531764,801743,927
   Common Stock
156,000
249,600
249,600
249,600
449,280
449,280
449,280
449,280
449,280
483,780
483,780
524,818
839,709
839,709
965,532
965,532
965,532
965,532
965,532
965,532
965,532
1,196,032
0
01,196,032965,532965,532965,532965,532965,532965,532965,532839,709839,709524,818483,780483,780449,280449,280449,280449,280449,280249,600249,600249,600156,000
   Retained Earnings 
78,526
38,093
65,700
203,416
337,895
353,358
379,855
479,555
612,379
813,713
1,089,766
1,472,893
1,676,393
1,876,061
2,405,518
2,306,177
2,144,161
2,109,451
1,568,700
1,661,773
2,030,749
2,500,419
2,312,398
2,312,3982,500,4192,030,7491,661,7731,568,7002,109,4512,144,1612,306,1772,405,5181,876,0611,676,3931,472,8931,089,766813,713612,379479,555379,855353,358337,895203,41665,70038,09378,526
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,893
-4,296
-2,231
-498
-2,168
49,689
433,981
439,188
439,188433,98149,689-2,168-498-2,231-4,296-1,893000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue11,993,677
Cost of Revenue-6,949,393
Gross Profit5,044,2845,044,284
 
Operating Income (+$)
Gross Profit5,044,284
Operating Expense-10,878,554
Operating Income1,115,123-5,834,270
 
Operating Expense (+$)
Research Development454,232
Selling General Administrative2,706,101
Selling And Marketing Expenses-
Operating Expense10,878,5543,160,333
 
Net Interest Income (+$)
Interest Income28,381
Interest Expense-230,354
Other Finance Cost-13,251
Net Interest Income-215,224
 
Pretax Income (+$)
Operating Income1,115,123
Net Interest Income-215,224
Other Non-Operating Income Expenses-
Income Before Tax (EBT)776,6091,115,123
EBIT - interestExpense = -230,354
614,980
845,334
Interest Expense230,354
Earnings Before Interest and Taxes (EBIT)-1,006,963
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax776,609
Tax Provision-150,525
Net Income From Continuing Ops626,084626,084
Net Income614,980
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-215,224
 

Technical Analysis of Zhejiang Hisun Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zhejiang Hisun Pharmaceutical Co Ltd. The general trend of Zhejiang Hisun Pharmaceutical Co Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zhejiang Hisun Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhejiang Hisun Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 7.53 < 7.99 < 8.22.

The bearish price targets are: 7.27 > 6.43.

Tweet this
Zhejiang Hisun Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhejiang Hisun Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhejiang Hisun Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhejiang Hisun Pharmaceutical Co Ltd. The current macd is -0.12430265.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Zhejiang Hisun Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Zhejiang Hisun Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Zhejiang Hisun Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Zhejiang Hisun Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartZhejiang Hisun Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhejiang Hisun Pharmaceutical Co Ltd. The current adx is 24.40.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Zhejiang Hisun Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Zhejiang Hisun Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhejiang Hisun Pharmaceutical Co Ltd. The current sar is 7.27.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Zhejiang Hisun Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhejiang Hisun Pharmaceutical Co Ltd. The current rsi is 46.22. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Zhejiang Hisun Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartZhejiang Hisun Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhejiang Hisun Pharmaceutical Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Hisun Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Zhejiang Hisun Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartZhejiang Hisun Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhejiang Hisun Pharmaceutical Co Ltd. The current cci is -47.34891461.

Zhejiang Hisun Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartZhejiang Hisun Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhejiang Hisun Pharmaceutical Co Ltd. The current cmo is -2.34831041.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Zhejiang Hisun Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartZhejiang Hisun Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhejiang Hisun Pharmaceutical Co Ltd. The current willr is -59.09090909.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Zhejiang Hisun Pharmaceutical Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Zhejiang Hisun Pharmaceutical Co Ltd Daily Williams %R ChartZhejiang Hisun Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhejiang Hisun Pharmaceutical Co Ltd.

Zhejiang Hisun Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhejiang Hisun Pharmaceutical Co Ltd. The current atr is 0.20273301.

Zhejiang Hisun Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartZhejiang Hisun Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhejiang Hisun Pharmaceutical Co Ltd. The current obv is -125,287,711.

Zhejiang Hisun Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartZhejiang Hisun Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhejiang Hisun Pharmaceutical Co Ltd. The current mfi is 43.94.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Zhejiang Hisun Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartZhejiang Hisun Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhejiang Hisun Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-25ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Zhejiang Hisun Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhejiang Hisun Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.224
Ma 20Greater thanMa 507.603
Ma 50Greater thanMa 1007.764
Ma 100Greater thanMa 2008.501
OpenGreater thanClose7.360
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Zhejiang Hisun Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Zhejiang Hisun Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zhejiang Hisun Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhejiang Hisun Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Hisun Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Zhejiang Hisun Pharmaceutical Co Ltd.

Receive notifications about Zhejiang Hisun Pharmaceutical Co Ltd in your mailbox!